N-[(3R,4R)-3-fluoro-1-methylsulfonylpiperidin-4-yl]-5-[(3S,4S)-3-fluoropiperidin-4-yl]-2,6-naphthyridin-3-amine

C19H25F2N5O2S — CID 178016987

IUPACN-[(3R,4R)-3-fluoro-1-methylsulfonylpiperidin-4-yl]-5-[(3S,4S)-3-fluoropiperidin-4-yl]-2,6-naphthyridin-3-amine
SMILESCS(=O)(=O)N1CC[C@@H](Nc2cc3c([C@@H]4CCNC[C@H]4F)nccc3cn2)[C@H](F)C1
InChIInChI=1S/C19H25F2N5O2S/c1-29(27,28)26-7-4-17(16(21)11-26)25-18-8-14-12(9-24-18)2-6-23-19(14)13-3-5-22-10-15(13)20/h2,6,8-9,13,15-17,22H,3-5,7,10-11H2,1H3,(H,24,25)/t13-,15-,16-,17-/m1/s1
InChIKeyPRLSZYZDUOXXDF-MWQQHZPXSA-N
MW425.51 g/mol
LogP1.83
Rot. Bonds4

About N-[(3R,4R)-3-fluoro-1-methylsulfonylpiperidin-4-yl]-5-[(3S,4S)-3-fluoropiperidin-4-yl]-2,6-naphthyridin-3-amine

N-[(3R,4R)-3-fluoro-1-methylsulfonylpiperidin-4-yl]-5-[(3S,4S)-3-fluoropiperidin-4-yl]-2,6-naphthyridin-3-amine (PubChem CID 178016987) has the molecular formula C19H25F2N5O2S and a molecular weight of 425.51 g/mol. Its IUPAC name is N-[(3R,4R)-3-fluoro-1-methylsulfonylpiperidin-4-yl]-5-[(3S,4S)-3-fluoropiperidin-4-yl]-2,6-naphthyridin-3-amine.

Molecular Properties

Compound NameN-[(3R,4R)-3-fluoro-1-methylsulfonylpiperidin-4-yl]-5-[(3S,4S)-3-fluoropiperidin-4-yl]-2,6-naphthyridin-3-amine
PubChem CID178016987
Molecular FormulaC19H25F2N5O2S
Molecular Weight425.51 g/mol
Exact Mass425.17
IUPAC NameN-[(3R,4R)-3-fluoro-1-methylsulfonylpiperidin-4-yl]-5-[(3S,4S)-3-fluoropiperidin-4-yl]-2,6-naphthyridin-3-amine
SMILESCS(=O)(=O)N1CC[C@@H](Nc2cc3c([C@@H]4CCNC[C@H]4F)nccc3cn2)[C@H](F)C1
InChIInChI=1S/C19H25F2N5O2S/c1-29(27,28)26-7-4-17(16(21)11-26)25-18-8-14-12(9-24-18)2-6-23-19(14)13-3-5-22-10-15(13)20/h2,6,8-9,13,15-17,22H,3-5,7,10-11H2,1H3,(H,24,25)/t13-,15-,16-,17-/m1/s1
InChIKeyPRLSZYZDUOXXDF-MWQQHZPXSA-N
XLogP1.83
TPSA87.22 Ų
H-Bond Donors2
H-Bond Acceptors6
Rotatable Bonds4
Heavy Atoms29
Complexity

Lipinski Rule of Five

Passes Rule of Five

RuleValue
MW ≤ 500425.51
LogP ≤ 51.83
H-Bond Donors ≤ 52
H-Bond Acceptors ≤ 106

Analyze N-[(3R,4R)-3-fluoro-1-methylsulfonylpiperidin-4-yl]-5-[(3S,4S)-3-fluoropiperidin-4-yl]-2,6-naphthyridin-3-amine with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of N-[(3R,4R)-3-fluoro-1-methylsulfonylpiperidin-4-yl]-5-[(3S,4S)-3-fluoropiperidin-4-yl]-2,6-naphthyridin-3-amine?
The IUPAC name of N-[(3R,4R)-3-fluoro-1-methylsulfonylpiperidin-4-yl]-5-[(3S,4S)-3-fluoropiperidin-4-yl]-2,6-naphthyridin-3-amine (CID 178016987) is N-[(3R,4R)-3-fluoro-1-methylsulfonylpiperidin-4-yl]-5-[(3S,4S)-3-fluoropiperidin-4-yl]-2,6-naphthyridin-3-amine.
What is the SMILES notation for N-[(3R,4R)-3-fluoro-1-methylsulfonylpiperidin-4-yl]-5-[(3S,4S)-3-fluoropiperidin-4-yl]-2,6-naphthyridin-3-amine?
The canonical SMILES for N-[(3R,4R)-3-fluoro-1-methylsulfonylpiperidin-4-yl]-5-[(3S,4S)-3-fluoropiperidin-4-yl]-2,6-naphthyridin-3-amine is CS(=O)(=O)N1CC[C@@H](Nc2cc3c([C@@H]4CCNC[C@H]4F)nccc3cn2)[C@H](F)C1.
What is the InChIKey of N-[(3R,4R)-3-fluoro-1-methylsulfonylpiperidin-4-yl]-5-[(3S,4S)-3-fluoropiperidin-4-yl]-2,6-naphthyridin-3-amine?
The InChIKey is PRLSZYZDUOXXDF-MWQQHZPXSA-N. The full InChI is InChI=1S/C19H25F2N5O2S/c1-29(27,28)26-7-4-17(16(21)11-26)25-18-8-14-12(9-24-18)2-6-23-19(14)13-3-5-22-10-15(13)20/h2,6,8-9,13,15-17,22H,3-5,7,10-11H2,1H3,(H,24,25)/t13-,15-,16-,17-/m1/s1.
What are the key properties of N-[(3R,4R)-3-fluoro-1-methylsulfonylpiperidin-4-yl]-5-[(3S,4S)-3-fluoropiperidin-4-yl]-2,6-naphthyridin-3-amine?
N-[(3R,4R)-3-fluoro-1-methylsulfonylpiperidin-4-yl]-5-[(3S,4S)-3-fluoropiperidin-4-yl]-2,6-naphthyridin-3-amine has a molecular weight of 425.51 g/mol, XLogP of 1.83, 4 rotatable bonds, 2 hydrogen bond donors, and 6 hydrogen bond acceptors.
Where does this data come from?
All data for N-[(3R,4R)-3-fluoro-1-methylsulfonylpiperidin-4-yl]-5-[(3S,4S)-3-fluoropiperidin-4-yl]-2,6-naphthyridin-3-amine is sourced from PubChem (CID 178016987), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).